Package 70069-013-25

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 70069-013-25
Digits Only 7006901325
Product NDC 70069-013
Description

25 VIAL in 1 CARTON (70069-013-25) / 5 mL in 1 VIAL (70069-013-01)

Marketing

Marketing Status
Marketed Since 2022-01-29
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "1cf06d0b-356a-4f2a-af3c-bbcd7e24aae9", "openfda": {"upc": ["0370069011010", "0370069012017", "0370069013014", "0370069014011"], "unii": ["V92SO9WP2I"], "rxcui": ["238212", "1731582", "1731590"], "spl_set_id": ["a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (70069-013-25)  / 5 mL in 1 VIAL (70069-013-01)", "package_ndc": "70069-013-25", "marketing_start_date": "20220129"}], "brand_name": "Glycopyrrolate", "product_id": "70069-013_1cf06d0b-356a-4f2a-af3c-bbcd7e24aae9", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]"], "product_ndc": "70069-013", "generic_name": "Glycopyrrolate", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glycopyrrolate", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA211705", "marketing_category": "ANDA", "marketing_start_date": "20220129", "listing_expiration_date": "20261231"}